Dual-State Query is proposed, a physics-informed multimodal architecture that explicitly embeds the Monod-Wyman-Changeux model of allostery within a neural network that outperforms other baselines and provides useful thermodynamic inductive bias, while also exposing a clear limitation on low-homology receptors.
Abstract
Predicting the bioactivity profiles of small molecules against G protein-coupled receptors (GPCRs) is a challenge in drug discovery. Although deep learning has accelerated the prediction of binding affinities, existing approaches often struggle to distinguish between functional efficacies because they neglect dynamic conformational equilibria. Furthermore, structure-based methods are frequently limited by the scarcity of high-resolution active-state crystal structures and the indistinguishability of conformational states in static representations. To bridge the gap between black-box prediction and biophysical reality, we propose Dual-State Query (DSQ), a physics-informed multimodal architecture that explicitly embeds the Monod-Wyman-Changeux (MWC) model of allostery within a neural network. Unlike conventional models that rely on explicit 3D structures, DSQ utilizes learnable orthogonal queries to extract disentangled representations of active and inactive receptor states. These latent representations are governed by a novel neural MWC gating module, which mathematically derives the probability of receptor activation from thermodynamic competition between ligand-state affinities and the receptor's intrinsic conformational energy barrier. A contrastive ranking objective is also introduced to enforce differential affinity constraints, ensuring physical consistency. Extensive experiments demonstrate that DSQ outperforms other baselines, particularly for the agonist subset. Additional homology-stratified, temperature-sensitivity, perturbation, clustering, and efficiency analyses show that DSQ provides useful thermodynamic inductive bias, while also exposing a clear limitation on low-homology receptors. The code is available at https://github.com/jiankliu/DSQ.
LGBind is introduced, a structure-guided deep learning framework for generalized, ligand-conditioned binding site identification and demonstrates profound robustness and generalization in predicting novel ligand-target interactions, and demonstrates remarkable versatility.
Yun-Feng Li, Xing-Yu Liu, Yi-Jia Liu et al.· European journal of medicina...· 0 citations
Binding of biased ligands to a G protein-coupled receptor (GPCR) stabilizes specific receptor conformations, leading to distinct physiological responses. Recently, intra-transducer bias has emerged as an additional mechanism that fine-tunes receptor function by stabilizing specific architectures of the receptor-transdu...
The computational results indicate that the proposed Persistent Sheaf Laplacian learning (PSLL) model achieves strong predictive performance across benchmark datasets, highlighting its potential as an interpretable and mathematically grounded framework with promising generalizability for molecular machine learning and...
Mushal Zia, Benjamin Jones, Guo-Wei Wei· 0 citations
Most computational methods identify protein–ligand binding sites from ligand-bound (holo) protein structures, where the binding pocket is already preorganized. Although convenient for benchmarking, this setting differs from the practical drug discovery scenario, in which binding sites must be inferred from ligand-free...
Omid Mokhtari, Amirhosein Naghsh-Nilchi, B. Grüning et al.· bioRxiv· 0 citations
MultiGeo is a DTA prediction framework that explicitly leverages multiple protein conformations rather than a single snapshot, and introduces a disagreement-aware gating mechanism that adaptively fuses this ensemble representation with the dominant structure only when the additional conformers provide complementary inf...
Rui-Da Zeng, Cheng Guo, Ya-Jie Meng et al.· Proceedings of the Thirty-Fi...· 0 citations
Structure-based drug discovery is a widely used paradigm for the rational design of novel small molecule therapeutics. However, the benefits conferred by the use of structural information has seen limited adoption in machine learning, where ligand-only ("2D") models are still the industry standard for molecular propert...
Ben Kaminow, A. Payne, Hugo MacDermott-Opeskin et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.